Bubs Australia (ASX: BUB) has entered into a new share subscription agreement with its largest customer and lead Chinese distributor, Willis Trading.
The company's stock opened 2.3% higher as the market opened.
Willis will receive up to 29.5m Bubs shares based on conditional milestones. The sales targets are
$50m in FY22 for 9.5m shares
$80-120m in FY23 for up to 20m shares
The maximum amount represents 4.82% of Bubs’ current issued capital
“We have worked closely with Willis Trading over several years as our lead distribution partner for the Corporate Daigou Channel. Together we have successfully returned Bubs Daigou sales to high growth, delivering record revenues in the first half of FY22, increasing 276% on the prior year, now exceeding pre-COVID levels,” said Bubs CEO Kristy Carr.
“The next phase of our partnership is an exceptional and innovative opportunity to deepen our engagement with the Daigou Channel and get closer to our end consumers in China.”
Bubs shares experienced a sharp 39% rerate last October from 36 cents to 50 cents after announcing a rebound in infant formula sales.
This momentum carried through to the company’s first-half FY22 results, where the business delivered:
Revenue of $33.6m, up 84%
Group gross margin of 38%
Goat infant formula margin of 38% versus 34% a year ago
Branded product margin of 30% versus 21% a year ago
Net loss of -$601,925 versus -$12.9m a year ago
Looking ahead, management said they expect the second-half to deliver a “modest half-on-half growth in revenue and underlying EBITDA”.
Interestingly, Bubs stock is trading at 45 cents, slightly lower than where it was after the October announcement.
Citi has been the only major broker to have covered Bubs.
As of 24 February, the broker held a Buy rating with a 73 cent price target (60% upside).
Citi was overall pleased with the company’s first-half result, notably the breakeven earnings and jump in Daigou sales.
Get the latest news and insights direct to your inbox